Dachaigh › Dermatitis Atopach (Eczema) › Arkansas
Sgrùdaidhean clionaigeach Dermatitis Atopach (Eczema) ann an Arkansas
Tha 8 sgrùdaidhean airson Dermatitis Atopach (Eczema) a’ lorg phàirtichean aig làraichean ann an Arkansas.
Bailtean ann an Arkansas
Teacsa sgrùdaidh oifigeil (Beurla)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fort Smith
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06947993A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Arkansas Research Trials, North Little Rock
A’ fastadhÌre 3
Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06807281Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Hot Springs
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07298395A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Dermatology Trial Associates, Inc, Bryant
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Applied Research Center and Wellness Clinic /ID# 268547, Little Rock
A’ fastadhÌre 3
Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, North Little Rock
A’ fastadhÌre 3
6 Months – 11 Years · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville
A’ fastadhÌre 3
Aoisean 18 gu 63 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT06389136A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
- Arkansas Research Trials, North Little Rock
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Sult 2025 · NCT06055361Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.